In June 2012, Medtronic held an Investor Conference to describe its upcoming products and expectations for the next five years. One of the biggest news items for...
Type 2 Diabetes News
Type 2 Diabetes is a chronic condition involving high blood sugar levels and reduced production and responsiveness to insulin.
39 readers recommended
When it comes to patient advocacy, Kerri Morrone Sparling explains why even the little things can have a big impact.
48 readers recommended
On December 14, the FDA granted 510(k) clearance for Insulet’s next-generation, much smaller OmniPod insulin patch pump, concluding a lengthy 19-month US regulatory...
59 readers recommended
Dr. Diana Guthrie, winner of the AADE Living Legend Award, on controlled breathing and supplements for people with diabetes…
85 readers recommended
By Hannah Deming Lately, the use of basal insulins (such as Lantus and Levemir) in combination with GLP-1 agonists (such as Byetta , Victoza , and Bydureon ) has been...
43 readers recommended
The Journal of the American Medical Association (JAMA) published a controversial meta-analysis suggesting that people who are overweight (a body mass index [BMI] of 25-...
34 readers recommended
Earlier this month, the American Diabetes Association (ADA) and the co-chairs of the Senate Diabetes Caucus, Senator Susan Collins (R-ME) and Jeanne Shaheen (D-NH),...
28 readers recommended
On October 18, Reata and Abbott stopped their phase 3, 2,000-patient BEACON trial for the drug bardoxolone methyl, the most promising candidate in development for the...
66 readers recommended
Gary Scheiner shares how to make your blood glucose data work for you.
23 readers recommended
Visiting your healthcare team? Kerri Sparling highlights the right questions to ask.
51 readers recommended
In May, Johnson & Johnson submitted its SGLT-2 inhibitor canagliflozin for approval in the US. On average, the FDA takes about ten months to review applications for...
29 readers recommended
(S)he said what?!? Last updated September 13, 2012.
62 readers recommended
On November 14, the European Commission approved AstraZeneca and Bristol-Myers Squibb’s Forxiga (dapagliflozin) for type 2 diabetes throughout the European Union...
31 readers recommended
Two well-known endocrinologists debated the merits of inhaled insulin in the February edition of Diabetes Care.
54 readers recommended
As noted in new now next in diaTribe #37, Novo Nordisk announced in October 2011 that it had submitted its two new “next-generation” insulin products for approval in the...
37 readers recommended
The giant Consumer Electronics Show, held each January in Las Vegas, had a variety of devices relevant to diabetes and obesity this year. Media buzz surrounded the...
43 readers recommended
In March 2013, Novo Nordisk launched Tresiba (insulin degludec) , its new once-daily basal insulin for type 1 and type 2 diabetes, in the UK and Denmark. Tresiba will be...